関連する実験動画
Updated: Sep 8, 2025

07:15
Intranasal Administration of CNS Therapeutics to Awake Mice
Published on: April 8, 2013
59.7K
慢性鼻炎に対する鼻内コルチコステロイドと粘液活性薬の効果と安全性
Li Hu1, Houyong Li1, Lu Yang1
1ENT Institute and Department of Otorhinolaryngology, Affiliated Eye and ENT Hospital of Fudan University, Shanghai, China.
International immunopharmacology
|September 5, 2025
まとめ
この研究では,ブデソニド鼻噴霧とエウカリプトルリモネンピネン (ELP) カプセルを組み合わせることで,ブデソニド単独投与よりも慢性鼻炎 (CRS) の症状が改善されたことが判明しました. この組み合わせ治療は,特にCRSの喫煙者にとって有望である.
科学分野:
- 耳鼻喉科
- 薬理学について
- 臨床試験の研究
背景:
- 慢性鼻炎 (CRS) は,世界的な健康と経済的負担を伴う.
- CRSの既存の治療法は,有効性と患者のアウトカムを改善するためにさらなる調査を必要としています.
- CRSの症状を管理し,生活の質を改善するための新しい治療戦略の必要性は極めて重要です.
研究 の 目的:
- 鼻内コルチコステロイドと粘液活性薬の併用によるCRS治療の有効性と安全性を評価する.
- エウカリプトルリモネンピネン (ELP) 腸内カプセルと併用したブデソニド鼻噴霧の治療の可能性を評価する.
- CRS患者における主観的な症状スコアと客観的な測定値に対するこの組み合わせ療法の影響を決定する.
主な方法:
- 13の病院で291人の成人CRS患者を対象としたランダム化,ダブルブラインド,プラセボ対照試験です.
- 参加者はブデソニド鼻噴霧とELPカプセル,またはブデソニド鼻噴霧とプラセボを投与された.
- 主要エンドポイントは,基礎値から第8週までのメジャー症状スコア (MSS) の変化でした.
主要な成果:
- ブデソニド・ELP群は,ブデソニド・プラセボ群と比較して,第4週にMSSの改善が顕著であった (P=0. 012).
- ブデソニドELPを投与された患者は,鼻の詰まり,鼻水漏れ,鼻,アノスミアの改善を8週目に示した (すべてP < 0. 05).
- CTスキャンでは,ブデソニドELPを投与した喫煙者において第8週までに有意な改善がみられた (P=0. 022),他の客観的な測定では,グループ間の有意な差異は示されなかった.
結論:
- 鼻内ブデソニドとELP腸内カプセルを併用した治療は,成人CRS患者にとって潜在的に有益である.
- この治療法は主観的な症状緩和を促進し,慢性鼻炎の生理的回復を支援します.
- この組み合わせによる治療は,CRSを患っている喫煙者に特に有益であることを示唆しています.
さらに関連する動画
関連する概念動画
Drugs Used in Upper Respiratory Disorders: Overview
356
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
356
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
382
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
382
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
425
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
425
Upper Respiratory Drugs: Decongestants
370
Decongestants are a class of medications used primarily to alleviate nasal congestion, a common symptom resulting from allergies, colds, sinusitis, and other upper respiratory tract infections. These drugs work by activating α-adrenergic receptors, constricting small blood vessels in the nasal membranes. This action results in the opening of clogged nasal passages, thereby facilitating sinus drainage and relieving congestion.
Most decongestants are readily available over-the-counter in...
Most decongestants are readily available over-the-counter in...
370
Drugs Used in Lower Respiratory Disorders: Overview
573
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
573
Inhaled Medications
387
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
387

